vs
Side-by-side financial comparison of dLocal Ltd (DLO) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
dLocal Ltd is the larger business by last-quarter revenue ($337.9M vs $336.6M, roughly 1.0× Guardian Pharmacy Services, Inc.). dLocal Ltd runs the higher net margin — 16.5% vs 4.0%, a 12.4% gap on every dollar of revenue. On growth, dLocal Ltd posted the faster year-over-year revenue change (65.2% vs 2.2%).
dLocal Limited is a Uruguayan financial technology company. It provides cross-border payments connecting global merchants to emerging markets.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
DLO vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $337.9M | $336.6M |
| Net Profit | $55.6M | $13.5M |
| Gross Margin | 34.3% | 22.7% |
| Operating Margin | 18.6% | 5.3% |
| Net Margin | 16.5% | 4.0% |
| Revenue YoY | 65.2% | 2.2% |
| Net Profit YoY | 87.3% | 46.1% |
| EPS (diluted) | $0.18 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | $337.9M | $397.6M | ||
| Q3 25 | $282.5M | $377.4M | ||
| Q2 25 | — | $344.3M | ||
| Q1 25 | — | $329.3M | ||
| Q4 24 | $204.5M | — | ||
| Q3 24 | $185.8M | $314.4M |
| Q1 26 | — | $13.5M | ||
| Q4 25 | $55.6M | $20.9M | ||
| Q3 25 | $141.3M | $9.8M | ||
| Q2 25 | — | $9.0M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | $29.7M | — | ||
| Q3 24 | $90.8M | $-122.0M |
| Q1 26 | — | 22.7% | ||
| Q4 25 | 34.3% | 21.5% | ||
| Q3 25 | 36.5% | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | 40.9% | — | ||
| Q3 24 | 42.1% | 19.4% |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 18.6% | 7.7% | ||
| Q3 25 | 19.7% | 4.3% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | 20.7% | — | ||
| Q3 24 | 22.1% | -33.3% |
| Q1 26 | — | 4.0% | ||
| Q4 25 | 16.5% | 5.3% | ||
| Q3 25 | 50.0% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 48.9% | -38.8% |
| Q1 26 | — | $0.21 | ||
| Q4 25 | $0.18 | — | ||
| Q3 25 | $0.17 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $719.9M | $64.9M |
| Total DebtLower is stronger | $86.7M | — |
| Stockholders' EquityBook value | $569.4M | $232.4M |
| Total Assets | $1.5B | $426.9M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | $719.9M | $65.6M | ||
| Q3 25 | $604.5M | $36.5M | ||
| Q2 25 | — | $18.8M | ||
| Q1 25 | — | $14.0M | ||
| Q4 24 | $425.2M | — | ||
| Q3 24 | $560.5M | $37.2M |
| Q1 26 | — | — | ||
| Q4 25 | $86.7M | $0 | ||
| Q3 25 | $63.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $39.8M | — | ||
| Q3 24 | — | $34.3M |
| Q1 26 | — | $232.4M | ||
| Q4 25 | $569.4M | $217.9M | ||
| Q3 25 | $504.7M | $195.5M | ||
| Q2 25 | — | $179.7M | ||
| Q1 25 | — | $163.2M | ||
| Q4 24 | $489.0M | — | ||
| Q3 24 | $457.0M | $133.9M |
| Q1 26 | — | $426.9M | ||
| Q4 25 | $1.5B | $412.7M | ||
| Q3 25 | $1.4B | $390.0M | ||
| Q2 25 | — | $356.3M | ||
| Q1 25 | — | $334.0M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | — | $348.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.15× | 0.00× | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $100.4M | $6.1M |
| Free Cash FlowOCF − Capex | $99.8M | — |
| FCF MarginFCF / Revenue | 29.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.80× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | $378.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $100.4M | $34.6M | ||
| Q3 25 | $315.0M | $28.2M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | $-141.1M | — | ||
| Q3 24 | $108.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $99.8M | — | ||
| Q3 25 | $313.4M | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-141.6M | — | ||
| Q3 24 | $107.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.5% | — | ||
| Q3 25 | 110.9% | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -69.2% | — | ||
| Q3 24 | 57.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.6% | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | 1.80× | 1.65× | ||
| Q3 25 | 2.23× | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.86× | ||
| Q4 24 | -4.75× | — | ||
| Q3 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
